We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Vircell S.L.

Vircell is a biotechnology company specialized in the development and production of ready-to-use reagents for the dia... read more Featured Products: More products

Download Mobile App




Vircell Launches New Independent Molecular Control to Combat Monkeypox Outbreak

By LabMedica International staff writers
Posted on 31 Jul 2022
Print article
Image: Amplirun Monkeypox Virus DNA Control (Photo courtesy of Vircell)
Image: Amplirun Monkeypox Virus DNA Control (Photo courtesy of Vircell)

Despite the fact that the first human cases of monkeypox were reported in 1970 in several African countries, it has not been until May 2022 when multiple cases of monkeypox were identified in different non-endemic countries, causing the current outbreak. By the time that the WHO (World Health Organization) declared the Moneypox a public health emergency of international concern in July 2022, Vircell (Granada, Spain) had already developed several solutions in order to help laboratories to detect this new menace. Vircell has now launched a new independent molecular control, Amplirun Monkeypox Virus DNA Control, which will help laboratories all over the world to combat the current outbreak.

Vircell is a leading provider of independent external run controls for nucleic acid testing with a long-term career in infectious disease diagnostics. During the COVID-19 pandemic, the company had developed SARS-COV-2 detection kits in record time, and it has now once again demonstrated its ability to adapt to changing laboratory needs with the newest solutions. Among Vircell’s solutions to detect monkeypox, the Amplirun Monkeypox Virus DNA Control stands out as a positive amplification control which contains purified DNA of Monkeypox virus to be used as a control research technique based on nucleic acids amplification. Some of the product’s outstanding features are:

  • Complete genome DNA control.
  • Any target can be amplified.
  • Allows validation of RTPCR assays.
  • Precise concentration in copies/µl.
  • Non-infectious materials with inactivation certificate.
  • Lyophilized presentation ensures stability and reduces transport costs. No special transportation conditions are required.
  • Independent third-party controls valid for any molecular testing platform

Amplirun Monkeypox Virus DNA Control could be used as:

  • Quality assurance of the amplification testing.
  • Limit of detection and assay specificity.
  • Lot-to-lot verification assay.
  • Development, optimization and validation of new assays.
  • Training and trial purposes.
  • Regulatory requirements and accreditation compliance.

Related Links:
Vircell

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: A false color scanning election micrograph of lung cancer cells grown in culture (Photo courtesy of Anne Weston)

AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell

Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)

Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.